Home/Filings/4/0001610618-24-000137
4//SEC Filing

Sandison Taylor 4

Accession 0001610618-24-000137

CIK 0001610618other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:30 PM ET

Size

5.5 KB

Accession

0001610618-24-000137

Insider Transaction Report

Form 4
Period: 2024-09-30
Sandison Taylor
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-09-30+166,836166,836 total
    Exercise: $10.75Exp: 2034-09-29Common Stock (166,836 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of September 30, 2024.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001702287

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:30 PM ET
Size
5.5 KB